Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02272413
Title Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin Plus Chemotherapy in Patients With Lung Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim

lung non-small cell carcinoma


Carboplatin + Paclitaxel


Age Groups: adult
Covered Countries USA | ITA | ESP | DEU

No variant requirements are available.